+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier



The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier



Journal of Biological Chemistry 272(44): 28102



The peripheral type benzodiazepine receptor (PBR) binds benzodiazepines such as RO5-4864 and isoquinoline carboxamide derivatives such as PK11195. This receptor includes an Mr 18,000 isoquinoline-binding subunit predominantly located in mitochondrial mem- branes. This protein has been found to copurify with two other mitochondrial proteins, namely the outer membrane voltage-dependent anion channel (VDAC), also known as mitochondrial porin, and the inner membrane adenine nucleotide carrier. In vitro reconstitution experiments suggested that the PBR was a multimeric complex in which the isoquinoline binding site was on the Mr 18,000 subunit, denoted pk18, whereas the benzodiazepine binding site required the association of this subunit with VDAC to be expressed. Untransformed cells of the yeast Saccharomyces cerevisiae are devoid of specific binding sites for isoquinolines and benzodiazepines, whereas yeast cells transformed with a pk18-expressing vector exhibit RO5-4864 and PK11195 binding sites that are pharmacologically identical to those of the PBR. To clarify the role of VDAC and of the adenine nucleotide carrier, if any, in the constitution of the benzodiazepine binding site, yeast host strains were constructed in which the corresponding genes had been knocked out. Mitochondria prepared from pk18-producing cells devoid of either VDAC or adenine nucleotide carrier exhibit both benzodiazepine and isoquinoline carboxamide binding sites with little or no change in the Kd values as compared with the wild-type background. These results rule out the contention that VDAC is indispensable for establishing the benzodiazepine binding site and are in agreement with the hypothesis that the Mr 18,000 subunit carries both the isoquinoline carboxamide and benzodiazepine binding domains.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 009535018

Download citation: RISBibTeXText

PMID: 9346965


Related references

Isolation of the mitochondrial benzodiazepine receptor: association with voltage-dependent anion channel and the adenine nucleotide carrier. Proceedings of the National Academy of Sciences of the United States of America 89: 70-4, 1992

Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proceedings of the National Academy of Sciences of the United States of America 89(8): 3170-3174, 1992

Characterization of solubilized "peripheral type" benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative. Biochemical Pharmacology 34(2): 167-170, 1985

Labelling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization. Journal of Neurochemistry 41(6): 1744-1750, 1983

Increased expression of the peripheral-type benzodiazepine receptor-isoquinoline carboxamide binding protein mRNA in brain following portacaval anastomosis. Brain Research 758(1-2): 255-258, 1997

The peripheral-type benzodiazepine receptor in hepatic encephalopathy 1 Increased expression of PTBR-isoquinoline carboxamide binding protein in brain following portacaval anastomosis. Journal of Neurochemistry 69(Suppl. ): S107, 1997

Peripheral benzodiazepine receptor regulates vascular endothelial activations via suppression of the voltage-dependent anion channel-1. Febs Letters 586(9): 1349-1355, 2012

Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with tritium labeled pk 11195 1 2 chlorophenyl n methyl n 1 methylpropyl 3 isoquinoline carboxamide. Brain Research Bulletin 13(1): 69-78, 1984

Erythrocyte peripheral type benzodiazepine receptor/voltage-dependent anion channels are upregulated by Plasmodium falciparum. Blood 118(8): 2305-2312, 2011

The mitochondrial benzodiazepine receptor: evidence for association with the voltage-dependent anion channel (VDAC). Journal of Bioenergetics and Biomembranes 24(1): 63-69, 1992

Post natal development in the effects of pento barbital on tritium labeled diazepam binding to the central type benzodiazepine receptors and the peripheral type benzodiazepine binding sites. Japanese Journal of Pharmacology 33(Suppl.): 245P, 1983

The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Molecular Pharmacology 74(2): 443-453, 2008

Cloning and expression of a pharmacologically unique bovine peripheral-type benzodiazepine receptor isoquinoline binding protein. Journal of Biological Chemistry 266(21): 14082, 1991

The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry 44(29): 9924-9935, 2005

Nucleotide-binding sites in the voltage-dependent anion channel: characterization and localization. Journal of Biological Chemistry 281(9): 5938-5946, 2006